Use of SGLT2 inhibitors and agonists of GLP-1 receptors in cardiovascular diseases. Acervo Saúde [Internet]. 2025 Sep. 9 [cited 2026 Nov. 3];25(9):e21512. Available from: https://acervomais.com.br/saude/article/view/21512